FDA Peptide Reclassification 2026: What Researchers Need to Know
If you’ve been paying attention to the research peptide space this year, you’ve seen a lot of headlines about FDA reclassification, RFK Jr., and compounding pharmacies. Some of that coverage has been accurate. A lot of it hasn’t. People are drawing conclusions from incomplete information, and in a space where the legal nuances actually matter, […]
